Afuco™ Anti-Human L1CAM ADCC Therapeutic Antibody, ADCC Enhanced
Anti-L1CAM ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibody can bind to LlCAM that is a surface antigen of the cancer cell, and suppress the activity of LlCAM, thereby inhibiting the growth and metastasis of the cancer cells. More specifically, the monoclonal antibody binds to an IgI domain of LlCAM, and thus it can be used for diagnosis or treatment of cancers expressing LlCAM.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-458CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | L1CAM |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |